4 of 20 — Human Endeavors

🏥 Healthcare & Medicine

Direct life-or-death impact, and one of the largest sectors of any developed economy.

Cited 10.06% of global GDP in health expenditure, 2023. World Bank / WHO Global Health Expenditure Database
Twenty facets of healthcare & medicine

Ranked by real-world weight

Each item below is marked sourced (a real institution tracks or ranks it) or judgment (no such institution ranks it — included on domain knowledge, not fabricated data).

1Hospitals & clinical care
2Pharmaceuticals
3Health insurance
4Primary & outpatient care
5Medical devices
6Nursing
7Diagnostics & testing
8Vaccines
9Biotechnology
10Generic drugs
11Oncology / cancer drugs
12Cardiovascular drugs
13Mental health services
14Surgery
15Medical imaging
16Elder & long-term care
17Diabetes drugs & insulin
18Medical supplies (PPE)
19Telemedicine & telehealth
20Clinical trials & CROs
Institutionally tracked Editorial judgment

16 of 20 upgraded via aggressive institutional search. Hospitals (1) via WHO GHO hospital-bed-density indicator; Pharmaceuticals (2) via WHO GHO SDG indicator 3.b.3 (essential-medicines availability); Health insurance (3) via the WHO Global Health Expenditure Database's financing-scheme classification; Medical devices (5) via the WHO Global Atlas of Medical Devices; Nursing (6) via WHO GHO health-workforce data; Diagnostics & testing (7) via the WHO Model List of Essential In Vitro Diagnostics; Vaccines (8) via WHO/UNICEF WUENIC immunization-coverage estimates; Generic drugs (10) via the FDA's Orange Book, cross-checked against WHO/HAI generic-medicine indicators; Oncology (11) via the WHO Essential Medicines list's antineoplastics section plus WHO GHO chemotherapy-availability indicator; Cardiovascular drugs (12) via WHO GHO hypertension treatment-coverage indicators; Mental health (13) via the WHO Mental Health Atlas; Surgery (14) via WHO GHO surgeon-density and surgical-coverage indicators; Medical imaging (15) via WHO GHO/GAMD device-density indicators; Elder & long-term care (16) via the WHO Global Dementia Observatory's long-term-care indicators; Diabetes drugs & insulin (17) via the WHO NCD Country Capacity Survey's insulin-availability indicator; Clinical trials & CROs (20) via ClinicalTrials.gov (US NIH). Four items stay judgment: 4 (primary & outpatient care), 9 (biotechnology), 18 (medical supplies/PPE), and 19 (telemedicine) — no institutional tracker was confirmed live for any of these.
Item citations: WHO Global Health Observatory · WHO Global Health Expenditure Database · WHO Model List of Essential Medicines · WHO Global Atlas of Medical Devices · WHO Mental Health Atlas · FDA Orange Book · ClinicalTrials.gov

Part of 20 Human Endeavors — the sectors most essential to human life and most influential in the global economy. See the full ranked list, methodology, and every category's citations at /items/.